Showing 581 - 600 results of 1,071 for search '"B cell"', query time: 0.10s Refine Results
  1. 581

    Blastoid Variant Mantle Cell Lymphoma Expressing Aberrant CD3 and CD10 with Concurrent Small Lymphocytic Lymphoma: Establishment of a Clonal Relationship by B- and T-Cell Receptor... by Christopher L. Felten, Joel A. Chan, Dulce R. DeCastro, Jean Lopategui, Swapnil P. Rajurkar

    Published 2018-01-01
    “…Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin B-cell lymphoma typically expressing CD19, CD20, CD5, FMC-7, CyclinD1, and SOX-11 and harboring the IgH/CCND1 translocation. …”
    Get full text
    Article
  2. 582

    Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma by Ji Sun, Nan-sheng Cheng

    Published 2022-01-01
    “…The data revealed that the risk score was positively related to the infiltration of CD8+ T cells, B cell, T cell CD8+, neutrophil, macrophage, and myeloid dendritic cell. …”
    Get full text
    Article
  3. 583

    Regulation of the IgE response by T follicular regulatory cells by Alexander L. Dent

    Published 2025-01-01
    “…T follicular helper (TFH) cells expressing IL-4 are required for the development of IgE expressing B cells in the germinal center (GC). Ig somatic hypermutation and B cell selection in the GC leads to the development of high affinity allergen-specific IgE that promotes anaphylaxis, a severe form of allergic response. …”
    Get full text
    Article
  4. 584

    Transition of Thyroid Autoantibodies by Rituximab Treatment in Women with Rheumatoid Arthritis by Hüseyin Demirci, Ebru Aydoğan, Bilge Ceydilek

    Published 2024-10-01
    “…Rituximab was first used as a treatment for B-cell malign lymphoma, and it is currently used in the treatment of rheumatoid arthritis. …”
    Get full text
    Article
  5. 585

    Remission Achieved in Refractory Advanced Takayasu Arteritis Using Rituximab by D. Ernst, M. Greer, M. Stoll, D. Meyer-Olson, R. E. Schmidt, T. Witte

    Published 2012-01-01
    “…Given evidence of refractory disease activity on maximal standard therapy, we initiated rituximab, based on recently reported B-cell activity in TA.…”
    Get full text
    Article
  6. 586

    Immunoinformatic approach to the design of a novel multi-epitope vaccine against Leishmania major fused to human IgG-Fc by Mahmood Fadaie, Zabihollah Shahmoradi, Hossein Khanahmad

    Published 2024-12-01
    “…Experimental approach: The antigens were subjected to immunoinformatic prediction and screening of HTL, CTL, and B-cell epitopes. The multi-epitope protein was designed with significantly high-scoring epitopes and suitable linkers. …”
    Get full text
    Article
  7. 587

    Luteolin ameliorates rat model of metabolic syndrome-induced cardiac injury by apoptosis suppression and autophagy promotion via NR4A2/p53 regulation by Xiyan Dai, Bo Liang, Yaolin Sun

    Published 2025-01-01
    “…Cardiac NR4A2 and p53, as well as apoptotic (B-cell leukemia/lymphoma 2 [BCL-2], Caspase [CASP]-3, and CASP-9) and autophagic mediators (Sequestosome-1/p62, Microtubule-associated protein 1 A/1B-light chain 3 [LC3], and Beclin-1) were measured by RT-qPCR and ELISA. …”
    Get full text
    Article
  8. 588

    Common variable immunodeficiency: An uncommon cause of bronchiectasis, granulomatous disease, chronic liver disease, and enteropathy – Case report and review of literature by Veena Shamsudeen, Arun Hegde, Uday Bhanu Kovilapu, Nisha Verma, Anurag Jain

    Published 2020-01-01
    “…Common variable immune deficiency (CVID) is a primary immunodeficiency syndrome, characterized by a defective B cell function. Although there is no age or gender predilection, it is usually diagnosed between the second and fourth decades of life. …”
    Get full text
    Article
  9. 589

    Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression by Georgia Tsaouli, Elisabetta Ferretti, Diana Bellavia, Alessandra Vacca, Maria Pia Felli

    Published 2019-01-01
    “…While in adults, there is a higher chance of relapse. ALL may affect B-cell or T-cell lineages. Different genetic alterations characterize the two ALL forms. …”
    Get full text
    Article
  10. 590

    Transcriptional Profiling of Testis Development in Pre-Sexually-Mature Hezuo Pig by Zunqiang Yan, Qiaoli Yang, Pengfei Wang, Shuangbao Gun

    Published 2024-12-01
    “…Additionally, chemokine, B cell receptor, activation of immune response, and enzyme binding were enriched in macrophages. …”
    Get full text
    Article
  11. 591

    Cutaneous Mucormycosis Co-infection in a Patient with COVID-19 by Raham Rahgoshai, Peter Goldberg, Rayhaneh Rahgoshai, Shadi Zain

    Published 2022-10-01
    “…The patient, whose history included therapy for diffuse large B-cell lymphoma, had an incidental positive screening test for COVID-19 in February 2021 after exposure to a family member who had tested positive. …”
    Get full text
    Article
  12. 592

    HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome by Dhouha Bacha, Beya Chelly, Houda Kilani, Lamia Charfi, Amel Douggaz, Samia Chatti, Emna Chelbi

    Published 2017-01-01
    “…In this case, the differential diagnosis was discussed with an early stage of large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease. …”
    Get full text
    Article
  13. 593

    Follicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal Models by Xueli Fan, Chenhong Lin, Jinming Han, Xinmei Jiang, Jie Zhu, Tao Jin

    Published 2015-01-01
    “…Follicular helper CD4+ T (TFH) cells play a fundamental role in humoral immunity deriving from their ability to provide help for germinal center (GC) formation, B cell differentiation into plasma cells and memory cells, and antibody production in secondary lymphoid tissues. …”
    Get full text
    Article
  14. 594

    Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives by Giulia Motta, Michele Cea, Eva Moran, Federico Carbone, Valeria Augusti, Franco Patrone, Alessio Nencioni

    Published 2010-01-01
    “…The use of monoclonal antibodies in B-cell Non-Hodgkin's lymphomas (NHL) represents the greatest example of these advances, as the introduction of the anti-CD20 antibody rituximab has had a dramatic impact on how we treat this group of diseases today. …”
    Get full text
    Article
  15. 595
  16. 596

    Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model by Lisa Pfeuffer, Viola Siegert, Riccardo Trozzo, Katja Steiger, Roland Rad, Jürgen Ruland, Maike Buchner

    Published 2025-02-01
    “…Abstract Chronic lymphocytic leukemia (CLL) is a heterogeneous B cell malignancy characterized by the accumulation of functionally incompetent B lymphocytes. …”
    Get full text
    Article
  17. 597

    A Rare Presentation of Lymphoma of the Cervix with Cross-Sectional Imaging Correlation by Brinda Rao Korivi, Corey T. Jensen, Madhavi Patnana, Keyur P. Patel, Tharakeswara K. Bathala

    Published 2014-01-01
    “…A 43-year-old asymptomatic female with a history of dual hit blastic B-cell lymphoma/leukemia in complete remission presented with an incidental cervical mass, which was initially felt to represent a cervical fibroid on computed tomography (CT). …”
    Get full text
    Article
  18. 598

    A Unique Case of Malignant Pleuropericardial Effusion: HHV-8-Unrelated PEL-Like Lymphoma—A Case Report and Review of the Literature by Farhan Mohammad, Muhammad Neaman Siddique, Faraz Siddiqui, M. Popalzai, Masoud Asgari, Marcel Odaimi

    Published 2014-01-01
    “…Primary effusion lymphoma (PEL) or body cavity lymphoma is a rare type of extra nodal lymphoma of B-cell origin that presents as lymphomatous effusion(s) without any nodal enlargement or tumor masses. …”
    Get full text
    Article
  19. 599

    Sporadic Burkitt Lymphoma Presenting with Middle Cranial Fossa Masses with Sphenoid Bony Invasion and Acute Pancreatitis in a Child by Tal Dror, Virginia Donovan, Naomi Strubel, Sucharita Bhaumik

    Published 2021-01-01
    “…Sporadic Burkitt lymphoma (BL) is an aggressive non-Hodgkin B-cell lymphoma that usually involves the bowel or pelvis, with isolated cases presenting as acute pancreatitis. …”
    Get full text
    Article
  20. 600

    Association of CVAI, LAP and SMI with risk of haematological toxicity after immunochemotherapy in patients with DLBCL: a retrospective study by Caifeng Liao, Hurong Lai, Yansong Tu, Ling He, Chuyang Lin, Huaijun Tu, Jian Li

    Published 2025-01-01
    “…Background: The occurrence of adverse events after immunochemotherapy in patients with diffuse large B-cell lymphoma (DLBCL) frequently affects the course of chemotherapy, leading to a further decline in quality of life and survival. …”
    Get full text
    Article